Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain

JUAN RAFAEL DE LA HABA RODRIGUEZ2026-01-292026-01-29201710.1007/s12094-017-1684-42-s2.0-85020107264https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/28144Cancer ResearchOncologyCancer ResearchOncologyCost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spainresearch article